Who owns BASEL MED GROUP LTD?
- Ticker: BMGL
- CUSIP Number: g0864b103
Tip: Access positions for across all investors
Analyze quarterly positions in Basel Med Group with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Basel Med Group stock
Who bought or sold BASEL MED GROUP LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| XTX Topco | 30k | $15k | 100% | Dec 2025 |
|
| Susquehanna International | 15k | $7.5k | 100% | Dec 2025 |
|
| T3 Companies | 15k | $8.9k | 100% | Mar 2026 |
|
| Renaissance Technologies | 15k | $7.1k | 100% | Dec 2025 |
|
| UBS Group | 13k | $7.7k | 61% | Mar 2026 |
|
| Coston, McIsaac & Partners | 50.00 | $0 | 0% | Mar 2026 |
|
Who sold out of Basel Med Group?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Sep 2025 | 34k | $61k |
| Ground Swell Capital | Dec 2025 | 34k | $17k |
| Citadel Advisors | Dec 2025 | 25k | $12k |
| Jane Street | Dec 2025 | 16k | $8.0k |
| Bell Investment Advisors | Dec 2025 | 248.00 | $121.991200 |